Genialis helps biotech companies to get the best out of their data in order to identify new drug targets or disease biomarkers. They empower biotech companies to interpret big data sets in medicine in a simple and intuitive way. Biotech companies can use the platform to identify predictive gene signatures and stratify patients for clinical trials. The software platform also allows to predict side effects or to validate drug targets. Their biomarkers are currently undergoing clinical trials for validation.